MorphoSys
IPOPlanegg, Germany · Founded 1992
- Headquarters
- Planegg
- Employees
- 201–500
- Founded
- 1992
- Business Model
- B2B
- Website
- morphosys.com
About
MorphoSys AG was a German biopharmaceutical company founded in 1992 and headquartered in Planegg, Germany, near Munich. The company pioneered proprietary antibody discovery technologies — most notably its Human Combinatorial Antibody Library (HuCAL) — used by researchers worldwide to generate highly specific, fully human antibodies for therapeutic and diagnostic applications. MorphoSys focused on the discovery, development, and commercialization of innovative antibody-based therapies for cancer and autoimmune diseases. In February 2024, Novartis agreed to acquire MorphoSys for approximately 2.7 billion euros, with the merger completed and MorphoSys delisted from the Frankfurt Stock Exchange in mid-2024.
Summary
MorphoSys is a Biotech company based in Planegg, Germany, founded in 1992.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2018
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...